Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / hoth therapeutics touts preclinical results for alzh

HOTH - Hoth Therapeutics touts preclinical results for Alzheimer's asset

Hoth Therapeutics Inc.

2023-08-09 10:51:01 ET

  • Results from a preclinical study of Hoth Therapeutics' ( NASDAQ: HOTH ) HT-ALZ for Alzheimer's disease found that the candidate led to improvement in areas of cognitive function.
  • More specifically, benefits were seen with spatial learning and memory, sensorimotor gating, and contextual associative memory.
  • The asset also showed a reduction in anxiety-type behavior in mice.
  • Due to the positive results, Hoth will begin formulation development of HT-ALZ.
  • Seeking Alpha's Quant Rating has viewed Hoth ( HOTH ) as a strong sell since Feb. 24 .

For further details see:

Hoth Therapeutics touts preclinical results for Alzheimer's asset
Stock Information
Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NYSE
Website: hoththerapeutics.com
Menu
HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...